Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor.

Cancers (Basel) · 2023 · PMC10705682 · PMID 38067332

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

on the threshold of significancep = 0.051so close (0.05 < p ≤ 0.1)

Despite ICOSLG, only being higher expressed in patients with an above-median PFS at T 0 , there was a trend towards patients with above-median PFS rates having higher levels of ICOSLG at T 2 , which was on the threshold of significance ( p = 0.051), while no trend was observed at T 1 ( p = 0.29). 3.3.

also in 22 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.